1. Home
  2. PRAX vs POOL Comparison

PRAX vs POOL Comparison

Compare PRAX & POOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$295.56

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Pool Corporation

POOL

Pool Corporation

HOLD

Current Price

$205.38

Market Cap

9.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
POOL
Founded
2015
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.5B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
PRAX
POOL
Price
$295.56
$205.38
Analyst Decision
Strong Buy
Buy
Analyst Count
15
10
Target Price
$572.13
$292.29
AVG Volume (30 Days)
298.8K
691.4K
Earning Date
05-01-2026
04-23-2026
Dividend Yield
N/A
2.50%
EPS Growth
N/A
N/A
EPS
N/A
10.85
Revenue
N/A
$5,289,396,000.00
Revenue This Year
N/A
$4.51
Revenue Next Year
$6,395.88
$3.98
P/E Ratio
N/A
$18.49
Revenue Growth
N/A
N/A
52 Week Low
$26.70
$197.68
52 Week High
$354.87
$345.00

Technical Indicators

Market Signals
Indicator
PRAX
POOL
Relative Strength Index (RSI) 42.98 36.28
Support Level $290.36 N/A
Resistance Level $322.32 $227.80
Average True Range (ATR) 16.81 5.69
MACD -2.42 0.38
Stochastic Oscillator 26.09 28.67

Price Performance

Historical Comparison
PRAX
POOL

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About POOL Pool Corporation

Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.

Share on Social Networks: